Blog

Emory Technology Transfer presents 12th Celebration of Technology & Innovation – Emory News Center


Emory News Center

Emory Technology Transfer presents 12th Celebration of Technology & Innovation
Emory News Center
Moore and his colleagues developed a live attenuated RSV vaccine using synthetic biology and reverse genetics to recode non-essential RSV genes and improve stability. This vaccine is the lead product being developed by the licensee, Meissa Vaccines

2018-03-05 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.